User talk:Kotroskin
Welcome...
Hello, Kotroskin, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful:
- Introduction
- The five pillars of Wikipedia
- How to edit a page
- Help
- How to write a great article
- Manual of Style
Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Questions, ask me on my talk page, or place {{helpme}} on your talk page and ask your question there. Again, welcome! Oo7565 18:12, 10 September 2007 (UTC)
Oo7565 18:12, 10 September 2007 (UTC)
Best að prófa líka til að vera svöl, ég er að skoða farmakófor og SAR. Vonast til að drita inn einhverjum línum um þetta síðar í kvöld. Elinborgus (talk) 20:27, 5 November 2008 (UTC)
See also populating
[edit]Edits such as [1] and to other members of the class of drugs are not needed, but many thanks for the good intention :-)
The leadin of the article lists what it is a member of, and "see also" tends to be fo rtangential issues not already covered in the article. Further there is a navigation box {{Angiotensin II receptor antagonists}} at the bottom of the page which gives full series of links. David Ruben Talk 19:02, 14 November 2008 (UTC)
DYK for Discovery and development of Angiotensin Receptor Blockers
[edit]
|
On 22 November, 2008, Did you know? was updated with a fact from the article Discovery and development of Angiotensin Receptor Blockers, which you created or substantially expanded. If you know of another interesting fact from a recently created article, then please suggest it on the Did you know? talk page. |